|
|
|
BrainCells, Inc.
BrainCells is developing novel therapies for affective and cognitive disorders based on proprietary neurogenesis technology.
|
| |
|
|
|
|
|
Cadence (NASDAQ: CADX)
Cadence Pharmaceuticals is a specialty pharmaceutical company focused on developing an IV formulation of acetaminophen for the management of peri-operative pain.
|
|
| |
|
|
|
|
|
|
Calypte Biomedical (AMEX: HIV)
Calypte Biomedical Corporation is a provider of diagnostic testing solutions for HIV, STDs, and other chronic diseases.
|
| |
|
|
|
|
|
Cardax Pharmaceuticals
Cardax Pharmaceuticals is developing proprietary drugs to reduce oxidative stress and inflammation. The lead compound is focused on preventing neurological damage and rethrombosis in stroke patients.
|
| |
|
|
|
|
|
Cell Pathways
Acquired by OSI Pharmaceuticals (NASDAQ: OSIP)
Cell Pathways (formerly NASDAQ: CLPA) developed drugs that induce selective apoptosis (programmed cell death) in precancerous and cancerous cells for the prevention and treatment of colon and lung cancers.
|
| |
|
|
|
|
|
CryoCor
Aquired by Boston Scientific (NYSE:BSX)
CryoCor (formerly NASDAQ: CRYO) is developing cryo-ablation devices for the minimally invasive treatment of atrial fibrillation and other cardiac arrhythmias.
|
| |
|
|
|
|
|
Cryogen
Aquired by American Medical Systems (NASDAQ:AMMD)
Cryogen produces low-temperature surgical devices for the women's health market.
|
|
| |
|
|
|
|
|
|
Cholestech
Aquired by Inverness Medical (NYSE:IMA)
Cholestech (formerly NASDAQ: CTEC) is a leading provider of diagnostic devices and information for point-of-care diagnostic testing for cholesterol and related lipids, blood glucose and glycemic control, inflammation and liver enzymes.
|
|
|
|
|
Ekos
Ekos develops ultrasound-enabled drug delivery devices for the treatment of stroke and peripheral applications.
|
| |
|
|
|
|
|
Emsense
Emsense applies advances in neuroscience to give consumer clients neuromarketing insights for creating advertising, content and products.
|
| |
|
|
 |
|
Epigenesis Pharmaceuticals
Epigenesis Pharmaceuticals is developing novel products for respiratory diseases. |
|
|
|
|
Essentialis
Essentialis is a clinical-stage pharmaceutical company targeted at obesity and other metabolic disorders.
|
|
| |
|
|
|
|
|
|
HeartStent
Acquired by Percardia
HeartStent is a medical device company targeted at the treatment of coronary artery disease. |
Incline Therapeutics |
|
Incline Therapeutics
Incline is a drug-device company targeted at post-operative patient-controlled analgesia.
|
|
|
|
Innercool Therapies
Aquired by Phillips (NYSE:PHG)
Innercool Therapies is the leader in therapeutic hypothermia devices to protect the brain from further injury following stroke, cardiac arrrest or brain surgery. |
| |
|
|
|
|
|
Iomai
Aquired by Intercell (VSX:ICLL) formerly (NASDAQ:IOMI)
Iomai is developing vaccines delivered via a novel, needle-free technology. The company's clinical-stage programs include seasonal flu, traveler's diarrhea and pandemic flu. |
|
| |
|
|
|
|
|
|
Iridex (NASDAQ:IRIS)
Iridex manufactures and markets light-based medical systems and delivery devices for multiple specialties including Aesthetic Medicine, Ophthalmology, and Otolaryngology. |
|
| |
|
|
|
|
|
|
Leptos Biomedical Aquired by St. June Medical (NYSE:SJM)
Leptos Biomedical is developing a proprietary neuromodulation therapy for obesity. The treatment, delivered via a pacemaker-type device, involves electrical activation of a specific nerve in the autonomic nervous system. |
|
| |
|
|
|
|
|
|
Medwave (NASDAQ: MDWV)
Medwave manufactures and markets a non-invasive monitoring system for measuring blood pressure. |
| |
|
|
|
|
|
NeuraLieve
Neuralieve is a medical technology company developing a hand-held device for the treatment of migraine headache. Neuralieve's core technology is based on the science of transcranial magnetic stimulation (TMS). |
|
| |
|
|
|
|
|
|
NeuroPace
NeuroPace is developing fully- implantable devices for the treatment of neurological disorders by responsive brain stimulation. The company's initial focus is the treatment of epilepsy. |
| |
|
|
|
|
|
Nfocus Neuromedical, Inc.
NFocus is developing novel neurovascular devices for the treatment of cerebral aneurysms and hemorrhagic stroke. |
| |
|
|
|
|
|
PercuSurge
Aquired by Medtronic (NYSE:MDT)
Percusurge was the pioneer in developing emboli-protection devices for the prevention of stoke and heart attack. |
| |
|
|
|
|
|
Revance Therapeutics
ReVance Therapeutics is a specialty pharmaceutical company focused on aesthetic dermatology. |
|
| |
|
|
|
|
|
|
Rinat Neuroscience
Acquired by Pfizer (NYSE:PFE)
Rinat is developing novel therapies based on anti-body technology for the treat of CNS disorders. |
| |
|
|
|
|
|
Saegis Pharmaceuticals
Acquired by Lundbeck Pharmaceuticals (OMX:LUN)
Saegis develops therapies for the treatment of Alzheimer's Disease and other memory disorders. |
| |
|
|
|
|
|
Solta Medical (NASDAQ:SLTM)
Solta Medical is producing and marketing non-invasive devices to tighten and contour skin, utilizing a proprietary combination of radio frequency energy and surface cooling technology. |
|
| |
|
|
|
|
|
|
Spinal Dynamics
Aquired by Medtronic (NYSE:MDT)
Spinal Dynamics develops neuro-surgical devices for the replacement of spinal disks. |
| |
|
|
|
|
|
|
Transcend Medical
Transcend Medical is focused on the research and development of novel devices for the treatment of glaucoma. |
|
| |
|
|
|
|
 |
|
Tria Beauty
Tria Beauty is a medical device company focused on bringing light-based dermatologic therapies into the home.
|
|
| |
|
|
|
|
|
|
Ventritex
Acquired by St. Jude Medical (NYSE:STJ)
Ventritex (formerly NASDAQ: VNTX) was a pioneer in the development of implantable defibrillators for the treatment of ventricular tachycardia and fibrillation. |
| |
|
|
|
|
|
|
Visiogen
Acquired by Abbott (NYSE:ABT)
Visiogen is developing the next generation of accommodating intraocular lens (IOL) for cataract surgery. |
|
